Search by Drug Name or NDC
NDC 50268-0731-24 Senna Syrup 8.8 mg/5mL Details
Senna Syrup 8.8 mg/5mL
Senna Syrup is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by AVPAK. The primary component is SENNOSIDES.
MedlinePlus Drug Summary
Senna is used on a short-term basis to treat constipation. It also is used to empty the bowels before surgery and certain medical procedures. Senna is in a class of medications called stimulant laxatives. It works by increasing activity of the intestines to cause a bowel movement.
Related Packages: 50268-0731-24Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Senna
Product Information
| NDC | 50268-0731 |
|---|---|
| Product ID | 50268-731_c1af768b-789b-2f88-e053-2995a90ad46b |
| Associated GPIs | 46200060201220 |
| GCN Sequence Number | 002922 |
| GCN Sequence Number Description | sennosides SYRUP 8.8MG/5ML ORAL |
| HIC3 | D6S |
| HIC3 Description | LAXATIVES AND CATHARTICS |
| GCN | 08660 |
| HICL Sequence Number | 001289 |
| HICL Sequence Number Description | SENNOSIDES |
| Brand/Generic | Generic |
| Proprietary Name | Senna Syrup |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Sennosides |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | LIQUID |
| Route | ORAL |
| Active Ingredient Strength | 8.8 |
| Active Ingredient Units | mg/5mL |
| Substance Name | SENNOSIDES |
| Labeler Name | AVPAK |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH NOT FINAL |
| Application Number | part334 |
| Listing Certified Through | 2022-12-31 |
Package
NDC 50268-0731-24 (50268073124)
| NDC Package Code | 50268-731-24 |
|---|---|
| Billing NDC | 50268073124 |
| Package | 24 CUP, UNIT-DOSE in 1 BOX (50268-731-24) / 5 mL in 1 CUP, UNIT-DOSE (50268-731-11) |
| Marketing Start Date | 2021-05-03 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |